Calcium oxalate crystal formation in patients with hyperparathyroidism and hyperthyroidism and related metabolic disturbances.
The crystallization of calcium oxalate in the urine of patients with hyperparathyroidism and hyperthyroidism was studied using a mixed suspension mixed product removal (MSMPR) system. In addition, calcium metabolism in hyperthyroidism and its relationship to urolithiasis was investigated. The urines from all the three groups (normal subjects, hyperparathyroid and hyperthyroid patients) showed reduced nucleation rates and increased growth rates in comparison with the control synthetic urine. The nucleation rate was not significantly different between the three human urine groups, while the growth rate was significantly higher in the hyperparathyroid group compared to the normal and hyperthyroid groups. Crystal volume (suspension density) in the hyperparathyroid group was approximately twice that in the other two groups. Serum and ionized calcium levels in hyperparathyroid patients were higher than in normal subjects, while hyperthyroid patients had levels only slightly higher than those in normal subjects. The hyperparathyroid and hyperthyroid groups differed significantly from the normal group in urinary calcium excretion. These two groups also showed significantly higher levels of serum alkaline phosphatase and urinary hydroxyproline than did the normal group. Although hyperthyroid patients have a calcium metabolism similar to hyperparathyroid patients, the incidence of urolithiasis is no different between hyperthyroid and normal subjects. The results of both crystallization and calcium metabolism in hyperparathyroid patients were not significantly different between those with and without urolithiasis. The result of crystallization was also not significantly different between hyperparathyroid patients with and without hypercalciuria. This study suggests that hypercalciuria alone does not produce urinary stones and that urine from hyperparathyroid patients may contain promotors of calcium oxalate crystallization and calcium stone formation.
Kohri
K
K
Department of Urology, Kinki University School of Medicine, Osaka, Japan.
Kodama
M
M
Umekawa
T
T
Ishikawa
Y
Y
Katayama
Y
Y
Takada
M
M
Katoh
Y
Y
Kataoka
K
K
Iguchi
M
M
Kurita
T
T
D002129:Calcium Oxalate / Q000652:urine*; D003460:Crystallization; D006801:Humans; D006961:Hyperparathyroidism / Q000097:blood / Q000150:complications / Q000652:urine*; D006980:Hyperthyroidism / Q000097:blood / Q000150:complications / Q000652:urine*; D014545:Urinary Calculi / Q000209:etiology*
D002129:Calcium Oxalate